D.C. Circuit Rejects Mylan's Bid To Make Generic Duragesic
The United States Court of Appeals for the District of Columbia Circuit upheld a June decision by the Food and Drug Administration and affirmed another court ruling that allowed Johnson & Johnson to retain exclusive rights to Duragesic until January as a reward for testing the effects of the drug on children.
The D.C. Circuit held that the FDA did not...
To view the full article, register now.